Rapid Idiosyncratic Mechanisms of Clinical Resistance to KRAS G12C Inhibition
Demographics (1)
- SEX - Biological sex (phv00496446.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00496451.v1.p1)
Other (12)
- AFFECTION_STATUS - Case control status of the subject for lung cancer (phv00496450.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00496454.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00496453.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00496445.v1.p1)
- IS_TUMOR - Tumor status (phv00496455.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00496457.v1.p1)
- SAMPLE_ID - Sample ID (phv00496452.v1.p1)
- SAMPLE_ID - Sample ID (phv00496448.v1.p1)
- SUBJECT_ID - Subject ID (phv00496444.v1.p1)
- SUBJECT_ID - Subject ID (phv00496449.v1.p1)
- SUBJECT_ID - Subject ID (phv00496447.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00496456.v1.p1)